StockData
Panacea Life Sciences Holdings, Inc. logo

Panacea Life Sciences Holdings, Inc. (PLSH) stock

PLSHOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Số liệu tài chính tới Q1 năm tài chính 2024, quý kết thúc ngày Mar 31, 2024Last filing: 10-Q on May 6, 2024
$0.07+0.00 (+5.45%)

Close on Oct 19, 2026Market cap $1.15MP/E –Yield –

Panacea Life Sciences operating margin

Operating margin is operating income as a percentage of revenue.

Panacea Life Sciences's operating margin for the twelve months ending Mar 31, 2024 was -192.2%. For fiscal 2023 it was -232.5%, against -347.4% the year before. The highest annual figure on record is -58.3% in fiscal 2020.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2023Dec 31, 2023-232.5%+114.9
FY2022Dec 31, 2022-347.4%−59.1
FY2021Dec 31, 2021-288.3%−230.0
FY2020Dec 31, 2020-58.3%+3029.2
FY2019Dec 31, 2019-3087.5%+179674.0
FY2015Dec 31, 2015-182761.5%−133435.4
FY2014Dec 31, 2014-49326.1%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q1 FY2024Mar 31, 2024-100.1%+90.3
Q4 FY2023Dec 31, 2023-184.1%+239.4
Q3 FY2023Sep 30, 2023-406.5%−27.3
Q2 FY2023Jun 30, 2023-269.1%−5.0
Q1 FY2023Mar 31, 2023-190.4%+162.9
Q4 FY2022Dec 31, 2022-423.5%−91.0
Q3 FY2022Sep 30, 2022-379.2%−165.2
Q2 FY2022Jun 30, 2022-264.1%+195.0
Q1 FY2022Mar 31, 2022-353.3%−140.1
Q4 FY2021Dec 31, 2021-332.5%−91.3
Q3 FY2021Sep 30, 2021-213.9%+35.3
Q2 FY2021Jun 30, 2021-459.1%−472.2
Q1 FY2021Mar 31, 2021-213.2%+101.9
Q4 FY2020Dec 31, 2020-241.2%+3571.4
Q3 FY2020Sep 30, 2020-249.2%+3110.0
Q2 FY2020Jun 30, 202013.0%+3372.2
Q1 FY2020Mar 31, 2020-315.0%+15929.4
Q4 FY2019Dec 31, 2019-3812.6%+28887.9
Q3 FY2019Sep 30, 2019-3359.2%+109526.7
Q2 FY2019Jun 30, 2019-3359.2%+31800.9
Q1 FY2019Mar 31, 2019-16244.4%−8215.3
Q4 FY2015Dec 31, 2015-32700.5%–
Q4 FY2014Dec 31, 2014-112885.9%–
Q3 FY2014Sep 30, 2014-35160.1%–
Q2 FY2014Jun 30, 2014-8029.1%–

More Panacea Life Sciences figures

See a number that looks wrong?